top of page
< Back

PolygenRx founders receive $7 million in funding to support their clinical and pre-clinical precision medicine research program

​

20 Dec 2023

​

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

PolygenRx

contact@polygenrx.com

Newcastle, NSW, Australia

​

Keywords: PolygenRx; precision medicine; companion diagnostics; targeted therapy; polygenic architecture; drug development, drug discovery; drug repurposing; pharmaceuticals; chronic disease; genetics; pharmagenic enrichment score (PES).

© 2022 PolygenRX

Website design and development by Rosalie Grierson-Burgess

Privacy Policy

Connect With Us On:

  • LinkedIn
  • Twitter
bottom of page